Chinese | English

Linkedbio is the newly launched services provided by Lingmed. We help companies to understand and monitor China market opportunities, define the right strategies and work with the right partners

Linkedbio Report No.158

In this month summary, Lingmed recommends

Introduction of Bio-Europe Spring
Assets recommendation
The January Financial analysis of global bio-pharmaceuticals market by Biotechgate data analysis team
Download the full report

Linkedbio Report No.157

LMP1031 project background

Allogeneic hematopoietic stem cell transplantation (allo - SCT) is an important method for curing various blood, genetics or immune disease, especially for patients with invasive blood malignant tumor, this method has become the only choice for treatment. However, graft versus host disease (GVHD) whether acute or chronic allo –had become the major obstacle to improve the effect of transplantation after SCT, which hindered the further clinical application for this technology
Download the full report

If you are interested in Lingmed historical achieved reports, please click here

Confirm your details on form below to download this report

Company name *
Your name *
Email *
Phone *

©Copyright 2013 - 2017 Lingmed Limited